Results 91 to 100 of about 1,984,318 (387)

Synthesis of Surface Active Agents. VI.

open access: yesJournal of Japan Oil Chemists' Society, 1961
The surface activity of the α-substituted higher aliphatic acids was studied. These compounds were prepared by reaction of α-bromo-fatty acid with various compounds, such as sodium hydroxide, N-methyltaurine, monoethanolamine, diethanolamine, glycine, n-butylamine, ethylenediamine, potassium cyanide (The obtained α-cyano-fatty acid was hydrolyzed into ...
Mikio KAWATA, Ryohei ODA, Yoshihiko ITO
openaire   +5 more sources

Anti-fog composition [PDF]

open access: yes, 1974
An anti-fog composition is described for the prevention of fogging on surfaces such as space helmet visors, spacecraft windows, and windshields.
Carmin, D. L., Jr., Morrison, H. D.
core   +1 more source

Effect of antistatic additives on mechanical and electrical properties of polyethylene foams [PDF]

open access: yes, 2009
Polyethylene foams with different antistatic additives (Atmer 7325, Atmer 7105, and Atmer 190) were prepared by extrusion and stored during 6 months of time span in a real life environment.
Brede   +11 more
core   +1 more source

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

open access: yesMolecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed   +10 more
wiley   +1 more source

Iron oxide nanoparticles and derivatives for biomedical imaging and application in cancer diagnosis and siRNA therapy [PDF]

open access: yes, 2011
This paper was presented at the 3rd Micro and Nano Flows Conference (MNF2011), which was held at the Makedonia Palace Hotel, Thessaloniki in Greece.
3rd Micro and Nano Flows Conference (MNF2011)   +2 more
core  

Strength through diversity: how cancers thrive when clones cooperate

open access: yesMolecular Oncology, EarlyView.
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken   +3 more
wiley   +1 more source

Enhancement of mechanical and electrical properties of continuous-fiber-reinforced epoxy composites with stacked graphene

open access: yesBeilstein Journal of Nanotechnology, 2017
Impregnation of expandable graphite (EG) after thermal treatment with an epoxy resin containing surface-active agents (SAAs) enhanced the intercalation of epoxy monomer between EG layers and led to further exfoliation of the graphite, resulting in stacks
Naum Naveh, Olga Shepelev, Samuel Kenig
doaj   +1 more source

Fabrication and Frosting Properties Study of Surface-Active Agents Coating Based on Nanoporous Aluminum Substrate

open access: yesEnergies, 2018
In order to solve the frosting and blockage problem of an air conditioning evaporator’s fin in winter, the nanoporous aluminum plates with low surface energy has been proposed in this paper, which are fabricated by an anodizing method and then ...
Song He   +4 more
doaj   +1 more source

Space Weathering on Near-Earth Objects investigated by neutral-particle detection

open access: yes, 2008
The ion-sputtering (IS) process is active in many planetary environments in the Solar System where plasma precipitates directly on the surface (for instance, Mercury, Moon, Europa). In particular, solar-wind sputtering is one of the most important agents
A. Milillo   +49 more
core   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy